Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection.
Moriguchi
Hisashi
H
Kobayashi
Makoto
M
Chung
Raymond T
RT
Sato
Chifumi
C
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins